Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, Akums Drugs and Pharmaceuticals has informed that it enclosed the proceedings of the 21st Annual General Meeting (AGM) of the Company held through Video Conference (VC)/ Other Audio-Visual Means (OAVM) on 18th July, 2025 at 11:00 AM (IST) and concluded at 11:57 AM (IST).
The above information is a part of company’s filings submitted to BSE.